Chong Kun Dang Pharmaceutical Corp. Logo

Chong Kun Dang Pharmaceutical Corp.

185750 | KO

Overview

Corporate Details

ISIN(s):
KR7185750007
LEI:
Country:
South Korea
Address:
서울 서대문구 충정로3가 3가 368 종근당빌딩, 서대문구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Regulatory Filings
투자판단관련주요경영사항 (텔미누보정(CKD828) 식품의약품안전처 국내 품목허가 승인)
Korean 7.2 KB
2025-08-22 00:00
Regulatory Filings
투자판단관련주요경영사항 (텔미누보정(CKD828) 식품의약품안전처 국내 품목허가 신청)
Korean 13.5 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 4.9 MB
2025-08-01 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-07-24 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 15.8 KB
2025-06-24 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 99.9 KB
2025-06-12 00:00
Regulatory Filings
유형자산취득결정
Korean 7.9 KB
2025-06-12 00:00
Regulatory Filings
풍문또는보도에대한해명(미확정)
Korean 8.0 KB
2025-06-10 00:00
Regulatory Filings
풍문또는보도에대한해명(미확정)
Korean 6.2 KB
2025-06-02 00:00
Governance Information
기업지배구조보고서공시
Korean 1.8 MB
2025-05-22 00:00
Regulatory Filings
기타경영사항(자율공시) (CKD510 기술수출 관련 마일스톤 수령)
Korean 5.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.9 MB
2025-04-30 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-04-23 00:00
Regulatory Filings
투자판단관련주요경영사항 (듀비엠폴서방정(CKD383) 식품의약품안전처 국내 품목허가 신청)
Korean 16.9 KB
2025-04-23 00:00
Regulatory Filings
투자판단관련주요경영사항 (듀비엠파정(CKD398) 식품의약품안전처 국내 품목허가 신청)
Korean 16.6 KB

Automate Your Workflow. Get a real-time feed of all Chong Kun Dang Pharmaceutical Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chong Kun Dang Pharmaceutical Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chong Kun Dang Pharmaceutical Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Dermapharm Holding SE Logo
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
Germany
DMP
Dermata Therapeutics, Inc. Logo
Develops OTC skin treatments using a unique delivery technology from freshwater sponges.
United States of America
DRMA
Design Therapeutics, Inc. Logo
Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.
United States of America
DSGN
Deutsche Biotech Innovativ AG Logo
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
Germany
DBI
DEVA HOLDİNG A.Ş. Logo
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain
DEVA
Devyser Diagnostics Logo
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
Sweden
DVYSR
DexTech Medical AB Logo
Developing pharmaceuticals for urological oncology using its proprietary GuaDex technology platform.
Sweden
DEX
DiaMedica Therapeutics Inc. Logo
Developing a novel protein therapy for acute ischemic stroke and preeclampsia.
United States of America
DMAC
Diamyd Medical AB (publ) Logo
Developing precision immunotherapies to preserve insulin in autoimmune diabetes.
Sweden
DMYD
Diasorin Logo
Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.
Italy
DIA

Talk to a Data Expert

Have a question? We'll get back to you promptly.